The Exchange
CNBC
Add to My Podcasts
Episodes
About
Reviews
Promote
Novo Nosedives, New AI Darlings & Buy the Former High-Flyers? 11/24/25
43 minutes
Posted Nov 24, 2025 at 7:46 pm.
0:00
43:44
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Novo Nordisk hits a 4-year low, just days after rival Eli Lilly hits a $1T market cap milestone.
Plus, some former high-flyers trading more down to earth. Is now the time to get in? And, two unlikely names dominating the AI narrative now.
Previous
Markets Rebound, Bitcoin Breaks Down & Google's Gains 11/21/25
Next
AI's Big Shift, Crushed Confidence & Retail's Best Buy 11/25/25
← See all 1775 episodes of The Exchange